Survival after metastasectomy for metastatic urothelial carcinoma: a systematic review and meta-analysis
Background: Cisplatin-based combination chemotherapy is standard treatment for metastatic urothelial carcinoma; however, the vast majority of patients experience disease progression. As systemic therapy alone is rarely curative for the treatment of metastatic urothelial cancer, not only are new ther...
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
IOS Press
2017
|
Online Access: | http://psasir.upm.edu.my/id/eprint/63341/1/Survival%20after%20metastasectomy%20for%20metastatic%20urothelial%20carcinoma.pdf http://psasir.upm.edu.my/id/eprint/63341/ https://pdfs.semanticscholar.org/e958/1988c469b086da736c9279e8c39808939969.pdf?_ga=2.28762367.2124675469.1537243130-311766275.1465439538 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://psasir.upm.edu.my/id/eprint/63341/1/Survival%20after%20metastasectomy%20for%20metastatic%20urothelial%20carcinoma.pdfhttp://psasir.upm.edu.my/id/eprint/63341/
https://pdfs.semanticscholar.org/e958/1988c469b086da736c9279e8c39808939969.pdf?_ga=2.28762367.2124675469.1537243130-311766275.1465439538